All articles by GBI Research

GBI Research

GBI is a business intelligence partner for companies in the healthcare sector, helping clients to better understand their business environment, compete successfully within it, and to achieve growth.

Comment

Here’s why getting less sleep could mean an increased risk of Alzheimer’s

Comment

Which class of drugs is set to have the biggest impact on the cancer market?

Comment

Sanofi is about to explode into the global dermatology market

Comment

Will a Brexit Health Alliance be able to protect the UK medical industry?

Comment

Better engagement is needed to combat the growing anti-vaxxer movement

Comment

Universal basic income: why has no country yet been brave enough to take the plunge?

Comment

The Great British Brexodus: is the UK facing a Brexit brain drain?

Comment

A new drug class could be set to reduce migraine misery

Comment

Is acne going to to benefit from biologics?

Comment

Here’s why getting less sleep could mean an increased risk of Alzheimer’s

Which class of drugs is set to have the biggest impact on the cancer market?

Sanofi is about to explode into the global dermatology market

Will a Brexit Health Alliance be able to protect the UK medical industry?

Better engagement is needed to combat the growing anti-vaxxer movement

Universal basic income: why has no country yet been brave enough to take the plunge?

The Great British Brexodus: is the UK facing a Brexit brain drain?

A new drug class could be set to reduce migraine misery

Is acne going to to benefit from biologics?

Relocating the EMA is bad news for the pharma industry and the health of 500m Europeans

Most Popular

US FTC launches inquiry into tech platform content moderation

Fluidstack in talks to raise $200m

Brazil Supreme Court fines X and faces Rumble

GBI Research

Subscribe to our Newsletter

Most Popular